About Us
Corporate Officers
Board of Directors
Community Citizenship
Our Brands
Makena
®
(hydroxyprogesterone caproate injection)
Evamist
®
(estradiol transdermal spray)
Clindesse
®
(clindamycin phosphate)
Gynazole-1
®
(Butoconazole Nitrate Vaginal Cream USP, 2%)
Ask the Healthcare Professional
Investor Relations
SEC Filings
News »
Recent Headlines
Press Releases
Conference Calls
Media Contacts
Upcoming Investor Events
Investor FAQs
Investor Contacts
Corporate Governance
Corporate Officers
Board of Directors
Research & Development
Update on Ongoing Makena
®
(hydroxyprogesterone caproate
injection) Research
5/22/2013 8:15:09 AM
KVPHQ:
KVPBQ:
Upcoming Investor Events
Company will update accordingly as Investor Events are scheduled.
Important Notice Regarding the Postponement of the
2012 Annual Meeting of Stockholders Originally Scheduled to be
Held on Thursday, September 13, 2012.
Archived Investor Events
Home
|
Contact Us
|
Site Directory
|
Legal/Privacy
|
Compliance Program
©2013 KV Pharmaceutical Company. All Rights Reserved.